Tirzepatide 40mg Vial
Tirzepatide is a modified 39-residue peptide studied in GLP-1/GIP receptor ligand pharmacology and structure research. The reference molecule includes Aib substitutions and a C20 fatty-diacid side chain; this is not batch-level verification.
Reference amino-acid sequence / identity: Y–Aib–E–G–T–F–T–S–D–Y–S–I–Aib–L–D–K–I–A–Q–K–A–F–V–Q–W–L–I–A–G–G–P–S–S–G–A–P–P–P–S (39-residue reference chain; C20 fatty-diacid side chain on Lys)